← Open Payments lookup

KELVIN POON: Open Payments

NPI 1316581812 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,304 in 307 payments from 19 companies in 2025. Trend: 2023 $2,589 · 2024 $3,713 · 2025 $7,304

Food & beverage: $7,192Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.36$919
ABBVIE INC.35$776
Otsuka America Pharmaceutical, Inc.36$754
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$753
Alkermes, Inc.25$562
Janssen Pharmaceuticals, Inc11$528
Vanda Pharmaceuticals Inc.29$495
E.R. Squibb & Sons, L.L.C.22$483
Teva Pharmaceuticals USA, Inc.16$483
Axsome Therapeutics, Inc.15$416

Products named: INGREZZA, REXULTI, VRAYLAR, CAPLYTA, FANAPT, COBENFY, Auvelity, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.